The ENA virtual meeting 2020
Published: 4 Nov 2020
Views: 77
Dr. Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
Dr Toni Choueiri speaks to ecancer about the important highlights of this year’s ENA virtual meeting and how they can impact cancer research in the future.
He speaks about a few upcoming clinical trials that can play a pivotal role in translational medicine and winds it up by thanking the organisers for a successful, informative meeting.
Related Videos
ESMO 2020 melanoma roundup
Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany
28 Sep 2020
ESMO 2020 renal roundup
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
25 Sep 2020
PARP inhibitors and their evolving role for the treatment of prostate cancer
Dr Neal Shore, Dr Neeraj Agarwal, Dr Elena Castro and Dr Kim Chi
24 Sep 2020
CD-19 mutation frequency after blinatumomab treatment is lower than after CAR T-...
Dr Michaela Kotrova - Universitätsklinikum Schleswig-Holstein, Kiel, Germany
20 Jun 2019
The changing landscape of AML
Prof Torsten Haferlach - MLL Münchner Leukämielabor GmbH, Munich, Germany
20 Jun 2019
Cutting-edge cancer care at the Miami Cancer Institute
Dr Miguel Villalona - Miami Cancer Institute, Miami, USA
18 Jun 2019
GU Debates 2019: Changing treatment paradigms for hormone-naïve and castration-r...
Dr Eleni Efstathiou, Prof Peter Goebell, Prof Joaquim Bellmunt, Prof Thomas Steu...
10 Apr 2019
Multiple myeloma highlights and more from ASH 2018
Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France
3 Dec 2018
ASH 2018: Expert overview of the latest in CLL, ALL and AML
Prof Robin Foa - University of Rome, Rome, Italy
3 Dec 2018
